Oncolytics Biotech (ONCY) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ONCY Hot Sheet
Join SI Premium – FREE
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- Benchmark Reiterates Buy Rating on Tower Semiconductor (TSEM) Following Japan Capacity Announcement
- Erste Group Downgrades Marvell (MRVL) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
